Harmony Biosciences Holdings, Inc. (HRMY)
39.64
+0.07
(+0.18%)
USD |
NASDAQ |
Oct 02, 16:00
39.64
0.00 (0.00%)
After-Hours: 20:00
Harmony Biosciences Holdings Market Cap : 2.304B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.304B |
| October 01, 2026 | 2.300B |
| September 30, 2026 | 2.282B |
| September 29, 2026 | 2.284B |
| September 28, 2026 | 2.325B |
| September 25, 2026 | 2.398B |
| September 24, 2026 | 2.392B |
| September 23, 2026 | 2.353B |
| September 22, 2026 | 2.414B |
| September 21, 2026 | 2.447B |
| September 18, 2026 | 2.442B |
| September 17, 2026 | 2.484B |
| September 16, 2026 | 2.453B |
| September 15, 2026 | 2.451B |
| September 14, 2026 | 2.414B |
| September 11, 2026 | 2.413B |
| September 10, 2026 | 2.389B |
| September 09, 2026 | 2.419B |
| September 08, 2026 | 2.445B |
| September 04, 2026 | 2.456B |
| September 03, 2026 | 2.433B |
| September 02, 2026 | 2.491B |
| September 01, 2026 | 2.397B |
| August 31, 2026 | 2.289B |
| August 28, 2026 | 2.279B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.317B |
| August 26, 2026 | 2.305B |
| August 25, 2026 | 2.264B |
| August 24, 2026 | 2.238B |
| August 21, 2026 | 2.217B |
| August 20, 2026 | 2.213B |
| August 19, 2026 | 2.321B |
| August 18, 2026 | 2.257B |
| August 17, 2026 | 2.217B |
| August 14, 2026 | 2.216B |
| August 13, 2026 | 2.238B |
| August 12, 2026 | 2.311B |
| August 11, 2026 | 2.297B |
| August 10, 2026 | 2.267B |
| August 07, 2026 | 2.232B |
| August 06, 2026 | 2.252B |
| August 05, 2026 | 2.213B |
| August 04, 2026 | 2.244B |
| August 03, 2026 | 2.060B |
| July 31, 2026 | 2.039B |
| July 30, 2026 | 2.075B |
| July 29, 2026 | 2.075B |
| July 28, 2026 | 2.070B |
| July 27, 2026 | 2.084B |
| July 24, 2026 | 2.044B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Liquidia Corp. | 2.552B |
| Pfizer Inc. | 158.43B |
| Bristol Myers Squibb Co. | 124.93B |
| Repligen Corp. | 10.25B |
| Johnson & Johnson | 616.58B |
Market Cap Related Metrics
| PE Ratio | 12.85 |
| PS Ratio | 2.426 |
| Price to Book Value | 2.306 |
| Price to Free Cash Flow | 6.937 |
| Price | 39.64 |
| Earnings Yield | 7.78% |
| Operating PE Ratio | 10.09 |
| Normalized PE Ratio | 12.85 |